{"id":"W3121771782","doi":"10.3390/curroncol28010066","title":"Real-World Palbociclib Use in HR+/HER2− Advanced Breast Cancer in Canada: The IRIS Study","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Pfizer","keywords":"Palbociclib; Fulvestrant; Medicine; Letrozole; Metastatic breast cancer; Internal medicine; Oncology; Breast cancer; Cancer; Progression-free survival; Gynecology; Aromatase; Chemotherapy; Estrogen receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006383562,0.0004188234,0.0004867372,0.001083862,0.001504943,0.001167041,0.001090813,0.0004141096,0.002089824],"category_scores_gemma":[0.002033163,0.000338926,0.0006033508,0.004779069,0.0005091067,0.000339322,0.0007962502,0.000670248,0.0003319365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0235941,"about_ca_system_score_gemma":0.03565654,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.980099,"about_ca_topic_score_gemma":0.9879745,"domain_scores_codex":[0.9987765,0.00007744296,0.00009915974,0.0002256369,0.0005076785,0.000313592],"domain_scores_gemma":[0.996754,0.00011499,0.001183212,0.0001481805,0.001351499,0.0004481255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003846054,0.00006779669,0.9907183,0.0001485986,0.0001452386,0.0001174599,0.0002614188,0.0001620906,0.0001423896,0.00009562297,0.003042103,0.004714493],"study_design_scores_gemma":[0.00008128236,0.00008027972,0.9945098,0.0001129113,0.0001707844,0.0002081468,0.0006074389,0.0002908364,0.0001254816,0.00002350287,0.003769096,0.00002037135],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9393955,0.002651636,0.0001539459,0.0005631743,0.00001873609,0.0003319072,0.04970285,0.00002744611,0.007154794],"genre_scores_gemma":[0.9819629,0.001509518,0.0003001844,0.0003801895,0.00001763358,0.0001165676,0.0146615,0.00001178922,0.001039639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0235941,"threshold_uncertainty_score":0.1711879,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07953434867907955,"score_gpt":0.4121547695590764,"score_spread":0.3326204208799969,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}